HIGHLIGHTS
- who: Thuy T. Tran et al. from the Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA have published the article: Authorship note: LBJ and HMK contributed equally to this work. Conflict of interest: HMK reports institutional research grants from Merck, Bristol-Myers Squibb, and Apexigen along with personal fees from Nektar, Iovance, Immunocore, Celldex, Array Biopharma, Merck, Elevate Bio, Instil Bio, Bristol- Myers Squibb, Clinigen, Shionogi, and Chemocentryx. SAW reports consulting work for Array Biopharma and MagellanRx. The funders had no role in the design of the study, in the collection, analyses, or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.